The effect of serine protease inhibitors on airway inflammation in a chronic allergen-induced asthma mouse model

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Lin, Chih Che ^a   Lin, Li Jen ^a   Wang, Shulhn Der ^a   Chiang, Chung Jen ^a   Chao, Yun Peng ^b   Lin, Joseph ^c   Kao, Shung Te ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b FENG CHIA UNIVERSITY   (Taiwan)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GABEXATE MESILATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; NAFAMSTAT MESILATE; ULINASTATIN; ALLERGEN; GABEXATE; GLYCOPROTEIN; GUANIDINE DERIVATIVE; NAFAMSTAT; SERINE PROTEINASE INHIBITOR;

AIRWAY RESISTANCE; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES PTERONYSSINUS; DRUG EFFECT; ENZYME ACTIVITY; EOSINOPHIL INFILTRATION; GOBLET CELL; HISTOLOGY; LONG TERM CARE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; TH17 CELL; TH2 CELL; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ALLERGENS; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; GABEXATE; GLYCOPROTEINS; GUANIDINES; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-6; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; SERINE PROTEINASE INHIBITORS;

EID: 84927173556     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/879326     Document Type: Article

References (37)

1. R. K. Kumar and P. S. Foster, "Modeling allergic asthma in mice: Pitfalls and opportunities, " The American Journal of Respiratory Cell and Molecular Biology, vol. 27, no. 3, pp. 267-272, 2002.
2. S. Saw, S. L. Kale, and N. Arora, "Serine protease inhibitor attenuates ovalbumin induced inflammation in mouse model of allergic airway disease, " PLoS ONE, vol. 7, no. 7, Article ID e41107, 2012.
3. K. Ckless, S. R. Hodgkins, J. L. Ather, R. Martin, and M. E. Poynter, "Epithelial, dendritic, and CD4+ T cell regulation of and by reactive oxygen and nitrogen species in allergic sensitization, " Biochimica et Biophysica Acta, vol. 1810, no. 11, pp. 1025-1034, 2011.
4. L. Cosmi, F. Liotta, E. Maggi, S. Romagnani, and F. Annunziato, "Th17 cells: New players in asthma pathogenesis, " Allergy, vol. 66, no. 8, pp. 989-998, 2011.
5. C. E. Reed and H. Kita, "The role of protease activation of inflammation in allergic respiratory diseases, " Journal of Allergy and Clinical Immunology, vol. 114, no. 5, pp. 997-1008, 2004.
6. F. Levi-Schaffer and A. M. Piliponsky, "Tryptase, a novel link between allergic inflammation and fibrosis, " Trends in Immunology, vol. 24, no. 4, pp. 158-161, 2003.
7. I. P. Lin, Y. S. Hsu, S. W. Kang, M. H. Hsieh, and J. Y. Wang, "Escherichia coli heat-labile detoxified enterotoxin modulates dendritic cell function and attenuates allergic airway inflammation, " PLoS ONE, vol. 9, no. 3, Article ID e90293, 2014.
8. G. Sun, M. A. Stacey, M. Schmidt, L. Mori, and S. Mattoli, "Interaction of mite allergens Der p3 and Der p9 with proteaseactivated receptor-2 expressed by lung epithelial cells, " Journal of Immunology, vol. 167, no. 2, pp. 1014-1021, 2001.
9. K. I. Inoue, H. Takano, R. Yanagisawa et al. , "Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide, " Experimental Biology and Medicine, vol. 230, no. 4, pp. 281-287, 2005.
10. F. Erba, L. Fiorucci, S. Pascarella, E. Menegatti, P. Ascenzi, and F. Ascoli, "Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug, " Biochemical Pharmacology, vol. 61, no. 3, pp. 271-276, 2001.
11. S. Mori, Y. Itoh, R. Shinohata, T. Sendo, R. Oishi, and M. Nishibiro, "Nafamostatmesilate is an extremely potent inhibitor of human tryptase, " Journal of Pharmacological Sciences, vol. 92, no. 4, pp. 420-423, 2003.
12. C.-L. Chen, S.-D. Wang, Z.-Y. Zeng et al. , "Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma, " Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 105-112, 2006.
13. K. Yasui, H. Kanda, T. Iwanami, and A. Komiyama, "Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation, " European Respiratory Journal, vol. 22, no. 5, pp. 739-742, 2003.
14. M. Ishizaki, H. Tanaka, D. Kajiwara et al. , "Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma, " Journal of Pharmacological Sciences, vol. 108, no. 3, pp. 355-363, 2008.
15. C. H. Katelaris, A. Linneberg, A. Magnan, W. R. Thomas, A. J. Wardlaw, and P. Wark, "Developments in the field of allergy in 2010 through the eyes of Clinical and Experimental Allergy, " Clinical and Experimental Allergy, vol. 41, no. 12, pp. 1690-1710, 2011.
16. Y. Yamamoto and R. B. Gaynor, "Therapeutic potential of inhibition of the NF-αB pathway in the treatment of inflammation and cancer, "The Journal of Clinical Investigation, vol. 107, no. 2, pp. 135-142, 2001.
17. C. K. Yu, C. M. Shieh, and H. Y. Lei, "Repeated intratracheal inoculation of house dust mite (Dermatophagoides farinae) induces pulmonary eosinophilic inflammation and IgE antibody production in mice, "The Journal of Allergy and Clinical Immunology, vol. 104, no. 1, pp. 228-236, 1999.
18. S. Wang, L. Lin, C. Chen et al. , "Xiao-Qing-Long-Tang attenuates allergic airway inflammation and remodeling in repetitive Dermatogoides pteronyssinus challenged chronic asthmatic mice model, " Journal of Ethnopharmacology, vol. 142, no. 2, pp. 531-538, 2012.
19. J. D. Brannan and M. D. Lougheed, "Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment, " Frontiers in Physiology, vol. 3, article 460, 2012.
20. M. D. P. T. N. Warth, E. A. L. Maldonado, S. M. Fernezlian et al. , "Neurokinin depletion attenuates pulmonary changes induced by antigen challenge in sensitized guinea pigs, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 268, no. 5, pp. L781-L788, 1995.
21. F. M. Arantes-Costa, S. Zoriki, M. H. C. Santos, C. H. P. Kobata, J. E. Vieira, and M. A. Martins, "Effects of ventilation, humidity and temperature on airway responsiveness to methacholine in rats, " European Respiratory Journal, vol. 19, no. 6, pp. 1008-1014, 2002.
22. J. Zhu and W. E. Paul, "CD4 T cells: fates, functions, and faults, " Blood, vol. 112, no. 5, pp. 1557-1569, 2008.
23. J. W. Steinke and L. Borish, "Th2 cytokines and asthma. Interleukin-4: Its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists, " Respiratory Research, vol. 2, no. 2, pp. 66-70, 2001.
24. P. S. Foster, A. W. Mould, M. Yang et al. , "Elemental signals regulating eosinophil accumulation in the lung, " Immunological Reviews, vol. 179, pp. 173-181, 2001.
25. M. E. Rothenberg and S. P. Hogan, "The eosinophil, " Annual Review of Immunology, vol. 24, no. 1, pp. 147-174, 2006.
26. S. T. Holgate and R. Polosa, "Treatment strategies for allergy and asthma, " Nature Reviews Immunology, vol. 8, no. 3, pp. 218-230, 2008.
27. A. Barczyk, W. Pierzcha, and E. Sozanska, "Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine, " Respiratory Medicine, vol. 97, no. 6, pp. 726-733, 2003.
28. S. Molet, Q. Hamid, F. Davoine et al. , "IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines, " The Journal of Allergy and Clinical Immunology, vol. 108, no. 3, pp. 430-438, 2001.
29. S. Schnyder-Candrian, D. Togbe, I. Couillin et al. , "Interleukin-17 is a negative regulator of established allergic asthma, " The Journal of ExperimentalMedicine, vol. 203, no. 12, pp. 2715-2725, 2006.
30. A. Linden, "Interleukin-17 and airway remodelling, " Pulmonary Pharmacology andTherapeutics, vol. 19, no. 1, pp. 47-50, 2006.
31. S. J. Park and Y. C. Lee, "Interleukin-17 regulation: an attractive therapeutic approach for asthma, " Respiratory Research, vol. 11, article 78, 2010.
32. A. Kimura and T. Kishimoto, "IL-6: Regulator of Treg/Th17 balance, " European Journal of Immunology, vol. 40, no. 7, pp. 1830-1835, 2010.
33. W. Al-Ramli, D. Prefontaine, F. Chouiali et al. , "TH17-associated cytokines (IL-17A and IL-17F) in severe asthma, " Journal of Allergy and Clinical Immunology, vol. 123, no. 5, pp. 1185-1187, 2009.
34. H. Moon, C. S. Kang, J. Choi et al. , "Acetyl salicylic acid inhibits Th17 airway inflammation via blockade of IL-6 and IL-17 positive feedback, " Experimental andMolecularMedicine, vol. 45, no. 1, p. e5, 2013.
35. J. L. Ather, S. R. Hodgkins, Y. M. W. Janssen-Heininger, and M. E. Poynter, "Airway epithelial NF-αB activation promotes allergic sensitization to an innocuous inhaled antigen, " The American Journal of Respiratory Cell andMolecular Biology, vol. 44, no. 5, pp. 631-638, 2011.
36. M. Pasparakis, "Regulation of tissue homeostasis by NF-B signalling: implications for inflammatory diseases, " Nature Reviews Immunology, vol. 9, no. 11, pp. 778-788, 2009.
37. H. Ogawa, M. Azuma, S. Muto et al. , "IαB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma, " Clinical and Experimental Allergy, vol. 41, no. 1, pp. 104-115, 2011.